Bioanalytics
.png)
Ely Porter, PhD
CSO
Dash Bio, Inc
Newton, Massachusetts
Description: Discover how automation and technology-first strategies are revolutionizing clinical bioanalysis. This session will showcase how integrating advanced platforms and workflows accelerates timelines, enhances data quality, and scales with program demands. Attendees will gain insight into real-world applications that are reshaping how the industry approaches PK, PD, and biomarker assays. Join us to explore the future of faster, smarter, and more reliable bioanalysis.